National Center of Competence in Resaerch, Switzerland Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2004
NCT00160992
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

NCCR | NCCR (National Center of Competence in Resaerch, Switzerland)

Active Ingredients

Drugs in Phase 2 Trials (1)

betahistine mesilate (1 trial)

Drugs in Phase 1 Trials (1)

melan-a analog peptide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 2)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2